Madrigal Pharmaceuticals, Inc. MDGL Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$288.28M+38.1% | -$465.89M-24.7% | -$373.63M-26.5% | -$295.35M-22.1% | ||
| $1.51M+37.4% | $1.1M+108% | $527K+12.8% | $467K+15.3% | ||
| $98.13M+22.8% | $79.88M+60.6% | $49.74M+57.3% | $31.63M+17.7% | ||
| $1.6M-23.2% | $2.09M-13.5% | $2.41M+203% | $797K— | ||
| $80.65M+49.9% | $53.82M— | —— | $0— | ||
| $36.98M+8.5% | $34.07M— | $0— | $0— | ||
| $5.28M— | —— | $4.21M+71.8% | $2.45M— | ||
| —— | —— | —— | $36.41M— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$455.57M-40.5% | -$324.23M-44.2% | -$224.86M-22.3% | ||
| —— | $1.46M-1.1% | $1.48M+582% | $217K+3.8% | ||
| $1.05B-7.4% | $1.13B+35.6% | $834.44M+482% | $143.48M-63.6% | ||
| $1.08B+25.5% | $863.28M+159% | $333.4M-4.8% | $350.38M-10.0% | ||
| —— | -$274.39M+50.4% | -$552.72M-367% | $206.69M— | ||
| —— | —— | —— | —— | ||
| $255.98M-65.2% | $735.06M+23.5% | $595.12M+89.9% | $313.45M+83.1% | ||
| —— | $0— | $0— | —— | ||
| —— | —— | —— | $295.28M— | ||
| $1.6M-23.2% | $2.09M-13.5% | $2.41M+203% | $797K— | ||
| $5.28M— | —— | $4.21M+71.8% | $2.45M— | ||
| $5.97M+124% | -$24.6M-318% | -$5.89M— | —— | ||
| —— | —— | —— | —— | ||
| $3.21M— | —— | —— | $0— | ||
| —— | —— | —— | —— | ||
| $1.08B+25.5% | $863.28M+159% | $333.4M-4.8% | $350.38M-10.0% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | $583K+55.1% | ||
| —— | -$457.03M-40.3% | -$325.71M-44.7% | -$225.07M-22.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Madrigal Pharmaceuticals, Inc. generate?
- Madrigal Pharmaceuticals, Inc. (MDGL) generated -$436.8M in operating cash flow over the trailing twelve months.
- What is Madrigal Pharmaceuticals, Inc.'s free cash flow?
- After $4.7M of capital expenditures, Madrigal Pharmaceuticals, Inc.'s free cash flow was -$440.3M over the trailing twelve months, up 3.7% year over year.
- Where does Madrigal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Madrigal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
